The rapid pace of change, which began in 2020 is unrelenting and ongoing. The high-stakes game has made many pharma leaders play defensive, instead of using the crisis to bring in the much-needed transformational changes. Leaders continue to rely on the traditional time-tested strategies, so that they can avoid the embarrassment of ‘losing’ in this…
Free Membership Required
You must be a Free member to access this content.
Already a member? Log in here
